LIPIDS, LIPOPROTEINS AND LIPID METABOLISM
WS01: Metabolism of atherogenic lipoproteins and their role in atherosclerosis
WS02: Cellular lipid metabolism, from uptake to storage
WS03: Mechanisms for the protective role of HDL
WS04: Reactive lipid compounds and modified lipoproteins in disease processes
FROM THE VULNERABLE PLAQUE TO THE VULNERABLE PATIENT– CHALLENGES FOR TRANSLATIONAL MEDICINE
WS05: Mechanisms for the progression and regression of atherosclerosis
WS06: Consequences of inflammation and immune response in atherosclerosis
WS07: Hypoxia and angiogenesis in the plaque
WS08: Nuclear receptors at the crossroad of lipid metabolism and inflammation
GENETICS, RISK FACTORS AND EPIDEMIOLOGY- FROM POPULATION TO PATIENTS
WS09: Joint Session with ESC: Thrombogenic risk factors for atherothrombosis and acute coronary events
WS10: Biomarkers - from bench to bedside
WS11: Psychosocial, socioeconomic and life style factors as determinants of cardiovascular disease
WS12: Novel genes related to atherogenesis and lipid metabolism – do they increase our understanding of the disease?
DIAGNOSIS, PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
WS13: Joint Session with EACPR: Healthy diets and functional food - a road to prevention
WS14: Cerebrovascular and carotid disease –prediction, prevention and treatment
WS15: Joint Session with ICCR: New challenges and targets of cardiovascular prevention and treatment
WS16: Imaging techniques in atherosclerosis, diagnostics and progress monitoring